Column Capital Advisors, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Column Capital Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2023	BUY	$705.89 - $766.39 $1,411 - $1,532	2 New	2 $1,000
Q1 2022 May 03, 2022	SELL	$595.12 - $698.43 $1,785 - $2,095	-3 Closed	0 $0
Q4 2021 Feb 07, 2022	BUY	$543.48 - $670.97 $1,630 - $2,012	3 New	3 $2,000
Q4 2020 Feb 12, 2021	SELL	$478.3 - $607.98 $9,087 - $11,551	-19 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$544.75 - $658.21 $11,439 - $13,822	-21 Reduced 52.5%	19 $11,000
Q1 2020 May 11, 2020	SELL	$336.18 - $494.43 $16,809 - $24,721	-50 Reduced 55.56%	40 $20,000
Q4 2019 Feb 14, 2020	BUY	$274.13 - $376.51 $24,671 - $33,885	90 New	90 $33,000

1,487

85.7M

1.53M

1.43M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.5B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Column Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Column Capital Advisors, LLC with notifications on news.